SOUTH SAN FRANCISCO, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose - Unleashing tools to accelerate breakthroughs in human health – today announced that it will report third quarter 2023 financial results on Tuesday, November 7, 2023, after the close of the market.…Read More
Related Posts
Thousand Oaks Biologics and GeneQuantum Healthcare Signed A Strategic Partnership Agreement for ADC Drug Development
Thousand Oaks Biologics Inc. (TOBio) and GeneQuantum Healthcare (Suzhou) Co., Ltd. (GQ) are pleased to announce that they have formed a strategic partnership focusing on the CMC development of ADC…
Pyrimidine Analogues Market Set to Register a Steady Revenue CAGR of 8 by 2031 Growth…
Newark, New Castle, USA, May 15, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports studied and calculated the size of the global market for pyrimidine Analogues in 2022 and expected it…
Digital PCR dPCR and Realtime PCR qPCR Market worth 124 billion MarketsandMarkets
CHICAGO, April 11, 2023 /PRNewswire/ -- The dPCR and qPCR industry is expected to experience significant growth in the near future. This is due to the increasing demand for precise,…
